Senseonics Holdings (SENS) Income from Continuing Operations (2015 - 2026)

Senseonics Holdings' (SENS) quarterly Income from Continuing Operations came in at 40964000.0 in Q1 2026, down 91.26% year-on-year from 468678927.35 in Q1 2025, and down 96.78% on a QoQ basis from 20817000.0 in Q4 2025.

Senseonics Holdings (SENS) Income from Continuing Operations (2015 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has 12 years of Income from Continuing Operations data on file, last reported at 40964000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 91.26% year-over-year to 40964000.0 in Q1 2026; TTM through Mar 2026 was 110003000.0, a 29.12% decrease from a year earlier, with the FY2025 full-year figure at 72036000.0, up 8.56% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 40964000.0, down from 20817000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for SENS reached as high as 10651000.0 in Q4 2022 and fell as low as 40964000.0 in Q1 2026.
  • Historically, Income from Continuing Operations has averaged 22207647.06 across 5 years, with a median of 21418000.0 in 2025.
  • Across the five-year window, Income from Continuing Operations surged 62.14% in 2022 and slumped 91.26% in 2026, its largest moves.
  • Year by year, Income from Continuing Operations stood at 10651000.0 in 2022, then slumped by 61.89% to 17243000.0 in 2023, then soared by 32.27% to 11678000.0 in 2024, then tumbled by 78.26% to 20817000.0 in 2025, then tumbled by 96.78% to 40964000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 40964000.0 in Q1 2026, 20817000.0 in Q4 2025, and 26500000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Senseonics Holdings 203.54 Mn 139.22 Mn 6.94 Mn -40.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -40.96 Mn
Dec 31, 2025 -20.82 Mn
Sep 30, 2025 -26.50 Mn
Jun 30, 2025 -21.72 Mn
Mar 31, 2025 -21.42 Mn
Dec 31, 2024 -11.68 Mn
Sep 30, 2024 -30.90 Mn
Jun 30, 2024 -21.19 Mn
Mar 31, 2024 -18.90 Mn
Dec 31, 2023 -17.24 Mn
Sep 30, 2023 -27.59 Mn
Jun 30, 2023 -22.01 Mn
Mar 31, 2023 -23.25 Mn
Dec 31, 2022 -10.65 Mn
Sep 30, 2022 -21.83 Mn
Jun 30, 2022 -21.31 Mn
Mar 31, 2022 -19.56 Mn
Dec 31, 2021 -28.14 Mn
Sep 30, 2021 -19.79 Mn
Jun 30, 2021 -19.68 Mn